Angiogenesis Inhibition in Advanced Non-Small-Cell Lung Cancer
Angiogenesis inhibition is an increasingly attractive strategy for the treatment of patients with lung cancer. Join us on Tuesday, September 26, at 1 PM EST, for a Web-based, CME live conference as Drs. Joan Schiller and Mark Socinski review antiangiogenesis in advanced NSCLC and describe ongoing research with agents in development.
This entry was posted on Tuesday, September 26th, 2006 at 8:56 am and is filed under Research, Education, Non-Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.